NGNE Neurogene PE ratio, current and historical analysis
The PE ratio for Neurogene stock stands at 0.49 as of Nov 21, 2024. This is calculated based on the TTM EPS of $31.92 and the stock price of $15.59 per share.
NGNE PE ratio history
Neurogene PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 0.7 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
NGNE average PE ratio chart
NGNE PE vs peers
In comparison to its peer stock ORMP, NGNE's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NGNE Neurogene Inc | 0.49 | $231.59M |
| ORMP Oramed Pharmaceuticals Inc | 21 | $93.12M |
| OLMA Olema Pharmaceuticals Inc | N/A | $450.93M |
| OMER Omeros Corp | N/A | $447.95M |
| OMGA Omega Therapeutics Inc | N/A | $42.96M |
| ONCT Oncternal Therapeutics Inc | N/A | $3.43M |
| ONVO Organovo Holdings Inc | N/A | $5.38M |
| ORIC Oric Pharmaceuticals Inc | N/A | $643.57M |
Frequently asked questions
What is Neurogene's PE ratio?
NGNE's price to earnings ratio is 0.49 as of Nov 21, 2024.
Why is Neurogene's PE ratio so low?
NGNE's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
How is NGNE's PE ratio calculated (Neurogene PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 21, 2024), Neurogene's share price is $15.59. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $31.92. Therefore, Neurogene's PE ratio for today is 0.49. PE RATIO(0.49) = STOCK PRICE($15.59) / TTM EPS($31.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.